Interview with Thomas Gardner, CEO of Biothech Company AtheraNova
Uploaded on Monday 26 March 2012
DESCRIPTION
AtheroNova (OTCBB: AHRO) is an early stage biotech company focused on discovery, research, development and licensing of novel compounds to reduce or regress atherosclerotic plaque deposits
DETAILS
Language: English
Length: 02:09
Country: United States
License:
Interview with Thomas Gardner, CEO of Biothech Company AtheraNova by bitLanders is licensed under a Creative Commons Attribution 3.0 License.
